Verily, the life sciences arm of technology giant Alphabet, has reached a deal to sell its insurance subsidiary to Elevance, the payer confirmed to Healthcare Dive on Friday. The subsidiary ...

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against other best health insurance stocks to buy in 2025. The health insurance sector in the US is ...

Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday.

In this article, we are going to take a look at where Elevance Health, Inc. (NYSE:ELV) stands against the other large-cap value stocks. The market outlook is as uncertain as it gets. On January 18 ...

Verily, Alphabet's life science group, entered an agreement to sell its insurance subsidiary to Elevance Health. In an email to staff last month, Verily CEO Stephen Gillett announced that Granular ...

Elevance Health (ELV – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Scott Fidel from Stephens downgraded the rating on the stock to a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health (ELV), reported Business Insider. Leverage the power ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...

Over the past year, many Elevance Health, Inc. (NYSE:ELV) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions ...

Elevance Health ELV has outperformed the market over the past 20 years by 1.37% on an annualized basis producing an average annual return of 9.81%. Currently, Elevance Health has a market ...